This report details the responses to Round Two applicability testing of the WP5 Adaptation Toolkit from 2007.
The first version of the toolkit was developed based on the results of a questionnaire, in-house thinking on content and function, and a Delphi survey of 19 European HTA agencies. From this a second version of the toolkit was developed (March 2007).
During Round 1 of applicability testing, evaluators from 16 European HTA agencies selected one or more HTA reports from a country other than theirs and tested the WP5 Adaptation Toolkit as an aid to adapting the report to meet the needs of their own health service, completing a specially designed qualitative evaluation sheet. Responses were submitted in May/June 2007 (and one in November 2007). Three of the evaluators took part in 1 hour face to face or telephone interviews to further explore their comments on the evaluation sheet.
From this feedback, refinements were made to the toolkit (version 3), and a different approach was adopted for the second round of applicability testing. Members of WP5 were invited to work in groups to examine the toolkit in respect of five topic areas, and to agree a joint response from each group. In addition, an opportunity was offered to members of WP4 and WP5 to use the Adaptation toolkit to adapt all or part of the WP4 Core HTA on Drug Eluting Stents. Finally, members of EUnetHTA outside WP5 or who had not worked on the development of the toolkit were invited to adapt a report of their choosing and comment using the evaluation form as in the first round of testing. Responses were received in March-May 2008 from the five WP5 workgroups representing all 20 Associated Partners and six Collaborating Partners, and in addition from three independent evaluators, details of which are given in the Appendices. These responses form the basis of this report.
Applicability Testing of WP5 toolkit – Round Two
